These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33050053)

  • 1. Evolutionary Analysis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reveals Genomic Divergence with Implications for Universal Vaccine Efficacy.
    Yellapu NK; Patel S; Zhang B; Meier R; Neums L; Pei D; Xia Q; Rotich D; Zimmermann RC; Nissen E; Bell-Glenn S; Shae W; Hu J; Chalise P; Chollet-Hinton L; Koestler DC; Thompson JA
    Vaccines (Basel); 2020 Oct; 8(4):. PubMed ID: 33050053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of Current Vaccine Development Strategies to Prevent Coronavirus Disease 2019 (COVID-19).
    Bennet BM; Wolf J; Laureano R; Sellers RS
    Toxicol Pathol; 2020 Oct; 48(7):800-809. PubMed ID: 32926660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic Evolution and Variation of SARS-CoV-2 in the Early Phase of COVID-19 Pandemic in Guangdong Province, China.
    Li BS; Li ZC; Hu Y; Liang LJ; Zou LR; Guo QF; Zheng ZH; Yu JX; Song T; Wu J
    Curr Med Sci; 2021 Apr; 41(2):228-235. PubMed ID: 33877539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing and Contrasting MERS, SARS-CoV, and SARS-CoV-2: Prevention, Transmission, Management, and Vaccine Development.
    Oves M; Ravindran M; Rauf MA; Omaish Ansari M; Zahin M; Iyer AK; Ismail IMI; Khan MA; Palaniyar N
    Pathogens; 2020 Nov; 9(12):. PubMed ID: 33255989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
    Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
    Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative genome analysis of novel coronavirus (SARS-CoV-2) from different geographical locations and the effect of mutations on major target proteins: An in silico insight.
    Khan MI; Khan ZA; Baig MH; Ahmad I; Farouk AE; Song YG; Dong JJ
    PLoS One; 2020; 15(9):e0238344. PubMed ID: 32881907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular evolution and phylogenetic analysis of SARS-CoV-2 and hosts ACE2 protein suggest Malayan pangolin as intermediary host.
    Lopes LR; de Mattos Cardillo G; Paiva PB
    Braz J Microbiol; 2020 Dec; 51(4):1593-1599. PubMed ID: 32592038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure of Nonstructural Protein 1 from SARS-CoV-2.
    Clark LK; Green TJ; Petit CM
    J Virol; 2021 Jan; 95(4):. PubMed ID: 33234675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspectives on development of vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
    Zhang C; Zhou C; Shi L; Liu G
    Hum Vaccin Immunother; 2020 Oct; 16(10):2366-2369. PubMed ID: 32961082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing.
    Kumar Y; Singh H; Patel CN
    J Infect Public Health; 2020 Sep; 13(9):1210-1223. PubMed ID: 32561274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
    Frederiksen LSF; Zhang Y; Foged C; Thakur A
    Front Immunol; 2020; 11():1817. PubMed ID: 32793245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Genomic Analysis of Rapidly Evolving SARS-CoV-2 Reveals Mosaic Pattern of Phylogeographical Distribution.
    Kumar R; Verma H; Singhvi N; Sood U; Gupta V; Singh M; Kumari R; Hira P; Nagar S; Talwar C; Nayyar N; Anand S; Rawat CD; Verma M; Negi RK; Singh Y; Lal R
    mSystems; 2020 Jul; 5(4):. PubMed ID: 32723797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CoronaVR: A Computational Resource and Analysis of Epitopes and Therapeutics for Severe Acute Respiratory Syndrome Coronavirus-2.
    Gupta AK; Khan MS; Choudhury S; Mukhopadhyay A; Sakshi ; Rastogi A; Thakur A; Kumari P; Kaur M; Shalu ; Saini C; Sapehia V; Barkha ; Patel PK; Bhamare KT; Kumar M
    Front Microbiol; 2020; 11():1858. PubMed ID: 32849449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryo-electron Microscopy Structure of the Swine Acute Diarrhea Syndrome Coronavirus Spike Glycoprotein Provides Insights into Evolution of Unique Coronavirus Spike Proteins.
    Guan H; Wang Y; Perčulija V; Saeed AFUH; Liu Y; Li J; Jan SS; Li Y; Zhu P; Ouyang S
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32817223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variations in SARS-CoV-2 Spike Protein Cell Epitopes and Glycosylation Profiles During Global Transmission Course of COVID-19.
    Xu W; Wang M; Yu D; Zhang X
    Front Immunol; 2020; 11():565278. PubMed ID: 33013929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic characterization and phylogenetic evolution of the SARS-CoV-2.
    Zhang RH; Ai X; Liu Y; Li CH; Zhang HL
    Acta Virol; 2020; 64(4):496-500. PubMed ID: 32985209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolutionary dynamics of SARS-CoV-2 nucleocapsid protein and its consequences.
    Rahman MS; Islam MR; Alam ASMRU; Islam I; Hoque MN; Akter S; Rahaman MM; Sultana M; Hossain MA
    J Med Virol; 2021 Apr; 93(4):2177-2195. PubMed ID: 33095454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolving geographic diversity in SARS-CoV2 and in silico analysis of replicating enzyme 3CL
    Chitranshi N; Gupta VK; Rajput R; Godinez A; Pushpitha K; Shen T; Mirzaei M; You Y; Basavarajappa D; Gupta V; Graham SL
    J Transl Med; 2020 Jul; 18(1):278. PubMed ID: 32646487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frontrunners in the race to develop a SARS-CoV-2 vaccine.
    Russell RL; Pelka P; Mark BL
    Can J Microbiol; 2021 Mar; 67(3):189-212. PubMed ID: 33264067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.